Messenger RNA (mRNA) transfection offers a versatile approach to achieve transient gene expression without genomic integration. Within pancreatic cancer research, mRNA delivery can be used to express tumor antigens for immunotherapy, produce CRISPR-Cas9 components for genome editing, or restore expression of tumor suppressor genes such as TP53. However, mRNA’s inherent lability and immunogenicity require specialized…
Transfection approaches in pancreatic research fall into two broad categories: in vitro gene delivery to cultured pancreatic cells and in vivo delivery to pancreatic tissues or tumors within animal models. Each method has distinct advantages and limitations, and the choice depends on experimental objectives. In vitro transfection affords tight control over variables such as cell…
In vivo transfection of pancreatic tissue involves the systemic or local introduction of nucleic acids into the pancreas of animal models—most commonly mice—where the therapeutic or experimental payload must traverse complex physiological barriers. The pancreas features a tight extracellular matrix, rich in collagen IV and laminin, and is highly vascularized with fenestrated capillaries, creating both…
Pancreatic cell lines are indispensable in vitro platforms for probing islet biology, exocrine function, and oncogenic pathways in pancreatic ductal adenocarcinoma (PDAC). Among the most frequently employed human pancreatic cancer cell lines are PANC-1, BxPC-3, MIA PaCa-2, AsPC-1, and Capan-1. Each line exhibits unique genetic and phenotypic characteristics: PANC-1 cells (KRAS^G12D mutant) model ductal adenocarcinoma…
In gene therapy and functional genomics, delivery method is as critical as the cargo. Viral vectors—such as lentivirus, adenovirus, and AAV—offer high efficiency and stable integration but come with immunogenicity, cost, and biosafety concerns. Non-viral methods, especially lipid-based transfection reagents like those from Altogen Biosystems, offer rapid, scalable, and low-toxicity alternatives. In pancreatic research, the…
2D monolayer cultures inadequately replicate the tumor microenvironment, prompting a shift toward 3D culture systems like spheroids and organoids. However, transfection efficiency in 3D structures is hampered by diffusion barriers, extracellular matrix components, and hypoxic cores. To overcome these challenges, Altogen’s reagents have been adapted for 3D delivery, employing nano-sized complexes capable of deep tissue…
Studying gene regulation in pancreatic cancer often necessitates co-delivery of functional siRNAs and reporter plasmids. This dual transfection strategy enables simultaneous knockdown of target genes and monitoring of downstream transcriptional activity. Altogen’s high-performance transfection reagents are designed for co-transfection in sensitive lines like Capan-1, BxPC-3, and MIA PaCa-2. By carefully optimizing the reagent-to-DNA:RNA ratio, researchers…
Epithelial-to-mesenchymal transition (EMT) is a hallmark of pancreatic cancer metastasis, conferring invasive potential and therapy resistance. BxPC-3 and PANC-1 cell lines are frequently employed to model EMT due to their epithelial and mesenchymal features, respectively. Transfection-based methods provide a powerful means to study EMT-related genes such as E-cadherin (CDH1), vimentin (VIM), and transcription factors like…
Pancreatic cancer remains one of the most lethal malignancies, with a five-year survival rate that lingers in the single digits. As research accelerates toward targeted therapies and precision medicine, gene manipulation techniques such as knockdown and knockout have become indispensable. But which is more suitable for pancreatic cancer models? Gene knockdown typically involves transient suppression…
Gene therapy is a promising and rapidly evolving field of medical research that aims to treat or prevent diseases by introducing, modifying, or repairing genetic material within a patient’s cells. It offers a potential solution for various genetic disorders, certain types of cancer, and some viral infections. Gene therapy can be broadly categorized into two…
